We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPremier African Minerals Regulatory News (PREM)

Share Price Information for Premier African Minerals (PREM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.19
Bid: 0.185
Ask: 0.195
Change: 0.00 (0.00%)
Spread: 0.01 (5.405%)
Open: 0.19
High: 0.1925
Low: 0.19
Prev. Close: 0.19
PREM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Zulu Lithium Additional Funding

30 Aug 2023 07:00

RNS Number : 7817K
Premier African Minerals Limited
30 August 2023
 

30 August 2023 

Premier African Minerals Limited

 

Zulu Lithium Additional Funding

Premier African Minerals Limited ("Premier" or the "Company"), is pleased to announce a conditional subscription for new ordinary shares by Canmax Technologies Co., Ltd ("Canmax") to raise £5 million before expenses at an issue price of 0.35 pence per new ordinary share for the ongoing Zulu Lithium and Tantalum Project ("Zulu") Pilot Optimisation where the Company is targeting revenue generating production by November 2023 ("Subscription").

 

Highlights:

Ø

The Subscription, together with the Placing funds (as announced on 25 August 2023) funds remaining expected operational expenditure and any shortfall in remedial expenses not met by the plant supplier for first revenue forecast for November 2023.

Ø

Subscription further not only confirms the commitment of Canmax, Premier largest shareholder, to the ultimate successful of Zulu, but is intended to facilitate increases in production capability.

George Roach, CEO commented, "Our interests are aligned, our intentions are clear. Zulu must produce now, and we must look to expand the capacity. We deeply appreciate this Subscription, that is as positive a statement of support and alignment as we could ever have asked for."

Subscription Agreement

 

On 28 August 2023, Premier and Canmax entered into a conditional subscription agreement ("Subscription Agreement") under which Canmax has conditionally agreed to subscribe £5 million before expenses for 1,428,571,428 new ordinary shares ("Subscription Shares") at an issue price of 0.35 pence within 15 business days following the entering into of the Subscription Agreement. On completion of the Subscription Canmax will be interested in 17.4 per cent in the enlarged issued share capital of Premier.

Conditions Precedent

Completion of the Subscription is conditional on the following:

i. Within 15 Business Days of the date of the Subscription, written confirmation that Canmax has received all applicable outbound direct investment approvals and/or registrations from and/or with competent Chinese administrative authorities with respect to the Subscription; and

ii. Each of the standard warranties for a transaction of this type as set out in the Subscription agreement being true and accurate as at the payment date.

 

The Placing has been arranged within the Company's existing share authorities. Premier intends to use the proceeds of the Subscription principally to provide funding to support the ongoing optimisation of the plant at Zulu and general working capital. In particular, Premier anticipates using the proceeds of the Subscription, together with the proceeds of the Placing announced on 25 August 2023, to meet the costs associated both with the interim mill installation that is expected to see production at 1,000 ton per month of spodumene from November 2023, the installation of a thickener and larger ball mill that is expected to see the plant achieve design throughput from Q1 2024.

Admission

The Subscription has been arranged within the Company's existing share authorities and the Subscription Shares will, when issued, rank pari passu in all respects with the existing ordinary shares. Application will be made for the Subscription Shares be admitted to trading on AIM and admission is expected to take place on or around 19 September 2022.

Related Party

Canmax is currently interested in more than 10 per cent. of the issued ordinary share capital of the Company, and the Subscription is a related party transaction for the purposes of Rule 13 of the AIM Rules. As previously announced, Dr Luo Wei was nominated by Canmax as a director of the Company and he is not independent for the purposes of the AIM Rules and the Subscription has therefore been considered by the Independent Directors (being the Board other than Dr Luo Wei). The Independent Directors of the Company consider, having consulted with the Company's nominated adviser, Beaumont Cornish, that the terms of the Subscription are fair and reasonable insofar as Shareholders are concerned. 

The Independent Directors have in particular taken into account that the Subscription is at the same issue price as the Placing announced on 25 August 2023, and provides additional funding to ensure that all anticipated cost associated with Zulu reaching commercial production in November are achievable. In addition, the Subscription provides additional contingency funding to cover any cash payment due in November in the event of any unforeseen delay of delivery of Spodumene in accordance with the amended agreement with Canmax as announced on 15 August 2023.

The Board also notes that Canmax, which is expected to maintain its interest in the Company, is listed on the Shenzhen Stock Exchange under the ticker 300390 with a market capitalisation of ¥22.9 Billion (£2.1billion) and has a track record of providing substantial shareholder support.

Market Abuse Regulation

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK Domestic Law by virtue of the European Union (Withdrawal) Act 2018.

The person who arranged the release of this announcement on behalf of the Company was George Roach.

A copy of this announcement is available at the Company's website, www.premierafricanminerals.com.

Enquiries

 

George Roach

Premier African Minerals Limited

Tel: +27 (0) 100 201 281

Michael Cornish / Roland Cornish

Beaumont Cornish Limited

(Nominated Adviser)

Tel: +44 (0) 20 7628 3396

Douglas Crippen

CMC Markets UK Plc

Tel: +44 (0) 20 3003 8632

Toby Gibbs/Rachel Goldstein

Shore Capital Stockbrokers Limited

Tel: +44 (0) 20 7408 4090

Jerry Keen

Fox-Davies Capital Limited

Tel: +44 (0) 20 3884 7447

 

Beaumont Cornish Limited, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting as nominated adviser to the Company in relation to the matters referred herein. Beaumont Cornish Limited is acting exclusively for the Company and for no one else in relation to the matters described in this announcement and is not advising any other person and accordingly will not be responsible to anyone other than the Company for providing the protections afforded to clients of Beaumont Cornish Limited, or for providing advice in relation to the contents of this announcement or any matter referred to in it.

 

Forward Looking Statements

Certain statements in this announcement are or may be deemed to be forward looking statements. Forward looking statements are identied by their use of terms and phrases such as ''believe'' ''could'' "should" ''envisage'' ''estimate'' ''intend'' ''may'' ''plan'' ''will'' or the negative of those variations or comparable expressions including references to assumptions. These forward-looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth results of operations performance future capital and other expenditures (including the amount. Nature and sources of funding thereof) competitive advantages business prospects and opportunities. Such forward looking statements reect the Directors' current beliefs and assumptions and are based on information currently available to the Directors. A number of factors could cause actual results to differ materially from the results discussed in the forward-looking statements including risks associated with vulnerability to general economic and business conditions competition environmental and other regulatory changes actions by governmental authorities the availability of capital markets reliance on key personnel uninsured and underinsured losses and other factors many of which are beyond the control of the Company. Although any forward-looking statements contained in this announcement are based upon what the Directors believe to be reasonable assumptions. The Company cannot assure investors that actual results will be consistent with such forward looking statements.

 

Notes to Editors

Premier African Minerals Limited (AIM: PREM) is a multi-commodity mining and natural resource development company focused on Southern Africa with its RHA Tungsten and Zulu Lithium projects in Zimbabwe.

 

The Company has a diverse portfolio of projects, which include tungsten, rare earth elements, lithium and tantalum in Zimbabwe and lithium and gold in Mozambique, encompassing brownfield projects with near-term production potential to grass-roots exploration. The Company has accepted a share offer by Vortex Limited ("Vortex") for the exchange of Premier's entire 4.8 per cent interest in Circum Minerals Limited ("Circum"), the owners of the Danakil Potash Project in Ethiopia, for a 13.1 per cent interest in the enlarged share capital of Vortex. Vortex has an interest of 36.7 per cent in Circum.

 

In addition, the Company holds a 19 per cent interest in MN Holdings Limited, the operator of the Otjozondu Manganese Mining Project in Namibia.

Ends

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCURUVROVUWORR
Date   Source Headline
12th Apr 20247:00 amRNSAdditional Funding for Zulu
11th Apr 20247:00 amRNSFunding of Zulu Project and Update
10th Apr 202412:00 pmRNSZulu Lithium Plant Update
8th Apr 20244:00 pmRNSResult of AGM
27th Mar 20245:00 pmRNSAGM Link and Shareholder Presentation
20th Mar 20246:00 pmRNSNotice of AGM
13th Mar 202411:00 amRNSZulu Lithium Plant and General Update
29th Feb 20246:00 pmRNSZulu Lithium Plant Update
26th Feb 20241:00 pmRNSZulu Lithium Plant Update
19th Feb 20246:00 pmRNSDirector Loan
15th Feb 20247:00 amRNSFunding of Zulu Project and Update
9th Feb 20247:00 amRNSNew Mineral Resource Statement Zulu
29th Jan 202411:15 amRNSOfftake and Prepayment Agreement
24th Jan 20247:00 amRNSZulu Lithium Update
18th Jan 20249:00 amRNSZulu Lithium Update
9th Jan 20247:00 amRNSZulu Assay Results and Update
11th Dec 202311:20 amRNSFunding of Zulu Project and Update
7th Dec 20233:00 pmRNSZulu Project and Update
20th Nov 20231:20 pmRNSZulu Update
14th Nov 202311:00 amRNSZulu Update
3rd Nov 20232:30 pmRNSZulu and Corporate Update
29th Sep 20237:05 amRNSZulu Lithium Update
29th Sep 20237:00 amRNSInterim Results
21st Sep 20238:00 amRNSZulu Lithium Update
15th Sep 20237:05 amRNSHolding(s) in Company
15th Sep 20237:00 amRNSHolding(s) in Company
11th Sep 20237:00 amRNSApproval of further funding for Zulu Project
1st Sep 20236:00 pmRNSTotal Voting Rights
30th Aug 20237:00 amRNSZulu Lithium Additional Funding
25th Aug 20237:00 amRNSFunding of Zulu Project
23rd Aug 20237:30 amRNSZulu Update
18th Aug 20233:23 pmRNSDirector/PDMR Shareholding
15th Aug 20231:30 pmRNSOfftake and Prepayment Agreement
14th Aug 20237:00 amRNSResult of Meeting
9th Aug 20236:00 pmRNSDirector Loan Update
21st Jul 20237:10 amRNSDirector's Loan
21st Jul 20237:00 amRNSNotice of GM
20th Jul 20237:00 amRNSOfftake and Prepayment Agreement Update
30th Jun 20232:57 pmRNSFinal Results
28th Jun 20234:37 pmRNSOfftake and Prepayment Agreement Update
26th Jun 20235:00 pmRNSResult of AGM
26th Jun 20237:00 amRNSOfftake and Prepayment Agreement Update
9th Jun 20237:00 amRNSNotice of AGM
6th Jun 202311:03 amRNSOfftake and Prepayment Agreement
25th May 20238:30 amRNSZulu Lithium Project Update
19th May 20237:00 amRNSFunding and Appointment of Joint Broker
15th May 20237:00 amRNSFunding of Ongoing Zulu Plant Optimisation
5th May 20235:00 pmRNSCorporate Update
28th Apr 20237:00 amRNSDirector / PDMR shareholding
27th Apr 20231:00 pmRNSZulu Lithium Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.